Want to join the conversation?
$ABBV will pay Stemcentrx about $2Bil of the transaction value in cash and fund the remaining portion with stock. Stemcentrx investors are eligible to receive up to $4Bil in cash for additional, success-based milestone payments for the achievement of some regulatory and clinical developments. $ABBV expects the deal to close in 2Q16.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!